FALINI, Brunangelo
FALINI, Brunangelo
"Designed" grafts for HLA-haploidentical stem cell transplantation.
2014 Martelli, Massimo Fabrizio; DI IANNI, Mauro; Ruggeri, Loredana; Pierini, Antonio; Falzetti, Franca; Carotti, Alessandra; Terenzi, A; Reisner, Y; Aversa, Franco; Falini, Brunangelo; Velardi, Andrea
[The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics]
2006 Paulli, M.; Artusi, T.; Baroni, C.; Carbone, A.; Coggi, G.; Di Lollo, S.; Facchetti, F.; Falini, Brunangelo; Et, a. L.
A BRAF-mutated case of hairy cell leukaemia lacking Annexin-A1 expression
2018 Simonetti, Edoardo; Ascani, Stefano; Volpetti, Stefano; Sabattini, Elena; Falini, Brunangelo; Tiacci, Enrico
A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin
2016 Cavalli, Marzia; Ilari, Caterina; Del Giudice, Ilaria; Marinelli, Marilisa; Della Starza, Irene; De Propris, Maria Stefania; De Novi, Lucia Anna; Nunes, Vittorio; Cafforio, Luciana; Raponi, Sara; Mancini, Francesca; Mauro, Francesca Romana; Tiacci, Enrico; Falini, Brunangelo; Guarini, Anna; Foà, Robin
A case of JAK2 V617F-positive myelodisplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course.
2011 Forghieri, F.; Morselli, M.; Potenza, L.; Maccaferri, M.; Pedrazzi, L.; Coluccio, V.; Barozzi, P.; Vallerini, D.; Riva, G.; Zanetti, E.; Quarelli, C.; Bonacorsi, G.; Artusi, T.; Zaldini, P.; Zucchini, P.; Marasca, R.; Narni, F.; Falini, Brunangelo; Torelli, G.; Luppi, M.
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course.
2011 Forghieri, F; Morselli, M; Potenza, L; Maccaferri, M; Pedrazzi, L; Coluccio, V; Barozzi, P; Vallerini, D; Riva, G; Zanetti, E; Quarelli, C; Bonacorsi, G; Artusi, T; Zaldini, P; Zucchini, P; Marasca, R; Narni, F; Falini, Brunangelo; Torelli, G; Luppi, M.
A curious novel combination of nucleophosmin (Npm1) gene mutations leading to aberrant cytoplasmic dislocation of npm1 in acute myeloid leukemia (aml)
2021 Venanzi, A.; Rossi, R.; Martino, G.; Annibali, O.; Avvisati, G.; Mameli, M. G.; Sportoletti, P.; Tiacci, E.; Falini, B.; Martelli, M. P.
A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
2000 Falini, Brunangelo; Fizzotti, M.; Pucciarini, A.; Bigerna, B.; Marafiori, T.; Gambacorta, M.; Pacini, R.; Alunni, C.; Natali Tanci, L.; Ugolini, B.; Sebastiani, C.; Cattoretti, G.; Pileri, S.; Dalla Favera, R.; Stein, H.
A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma.
2000 Trinei, M.; Lanfrancone, L.; Campo, E.; Pulford, K.; Mason, D.; Pelicci, P.; Falini, Brunangelo
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation
2015 Abate, F; Todaro, M; van der Krogt, J. A; Boi, M; Landra, I; Machiorlatti, R; Tabbò, F; Messana, K; Abele, C; Barreca, A; Novero, D; Gaudiano, M; Aliberti, S; Di Giacomo, F; Tousseyn, T; Lasorsa, E; Crescenzo, R; Bessone, L; Ficarra, E; Acquaviva, A; Rinaldi, A; Ponzoni, M; Longo, D. L; Aime, S; Cheng, M; Ruggeri, B; Piccaluga, P. P; Pileri, S; Tiacci, Enrico; Falini, Brunangelo; Pera Gresely, B; Cerchietti, L; Iqbal, J; Chan, W. C; Shultz, L. D; Kwee, I; Piva, R; Wlodarska, I; Rabadan, R; Bertoni, F; Inghirami, G.
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)
2008 Liso, A; Castiglione, F; Cappuccio, A; Stracci, Fabrizio; Schlenk, Rf; Amadori, S; Thiede, C; Schnittger, S; Valk, Pj; Döhner, K; Martelli, Massimo Fabrizio; Schaich, M; Krauter, J; Ganser, A; Martelli, Maria Paola; Bolli, N; Löwenberg, B; Haferlach, T; Ehninger, G; Mandelli, F; Döhner, H; Michor, F; Falini, Brunangelo
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice.
2013 Mupo, A; Celani, L; Dovey, O; Cooper, Jl; Grove, C; Rad, R; Sportoletti, Paolo; Falini, Brunangelo; Bradley, A; Vassiliou, Gs
A scale of "bad" co-mutations in NPM1-driven AML
2017 Falini, Brunangelo; Sportoletti, Paolo
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study
2016 Chiaretti, S.; Vitale, A.; Vignetti, M.; Piciocchi, A.; Fazi, P.; Elia, L.; Falini, B.; Ronco, F.; Ferrara, F.; De Fabritiis, P.; Luppi, M.; La Nasa, G.; Tedeschi, A.; Califano, C.; Fanin, R.; Dore, F.; Mandelli, F.; Meloni, G.; Foa, R.
Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif.
2007 Falini, Brunangelo; Albiero, E.; Bolli, N.; De Marco, M.; Madeo, D.; Martelli, Massimo Fabrizio; Nicoletti, Ildo; Rodeghiero, F.
Aberrant hypermutation of PIM1, PAX5, RhoH/TTF and cMYC in nodular lymphocyte predominance Hodgkin's disease
2005 Falini, Brunangelo; Liso, Arcangelo; Et, a. L.
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma.
2006 Liso, A; Capello, D; Marafioti, T; Tiacci, E; Cerri, M; Distler, V; Paulli, M; Carbone, A; Delsol, G; Campo, E; Pileri, S; Pasqualucci, L; Gaidano, G; Falini, B.
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML.
2006 Falini, Brunangelo; Bigerna, B; Pucciarini, A; Tiacci, Enrico; Mecucci, Cristina; Morris, Sw; Bolli, Niccolo'; Rosati, R; Hanissian, S; Ma, Z; Sun, Y; Colombo, E; Arber, Da; Pacini, R; LA STARZA, Roberta; Verducci Galletti, B; Liso, A; Martelli, Maria Paola; Diverio, D; Pelicci, Pg; Lo Coco, F; Martelli, Massimo Fabrizio
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML.
2008 Martelli, Maria Paola; Manes, N; Pettirossi, V; Liso, A; Pacini, R; Mannucci, R; Zei, T; Bolli, Niccolo'; di Raimondo, F; Specchia, G; Nicoletti, Ildo; Martelli, Mf; Falini, Brunangelo
Actinomycin d targets npm1c-primed mitochondria to restore pml-driven senescence in aml therapy
2021 Wu, H. -C.; Rerolle, D.; Berthier, C.; Hleihel, R.; Sakamoto, T.; Quentin, S.; Benhenda, S.; Morganti, C.; Wu, C.; Conte, L.; Rimsky, S.; Sebert, M.; Clappier, E.; Souquere, S.; Gachet, S.; Soulier, J.; Durand, S.; Trowbridge, J. J.; Benit, P.; Rustin, P.; Hajj, H. E.; Raffoux, E.; Ades, L.; Itzykson, R.; Dombret, H.; Fenaux, P.; Espeli, O.; Kroemer, G.; Brunetti, L.; Mak, T. W.; Lallemand-Breitenbach, V.; Bazarbachi, A.; Falini, B.; Ito, K.; Martelli, M. P.; de The, H.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Designed" grafts for HLA-haploidentical stem cell transplantation. | 2014 | Martelli, Massimo Fabrizio; DI IANNI, Mauro; Ruggeri, Loredana; Pierini, Antonio; Falzetti, Franca; Carotti, Alessandra; Terenzi, A; Reisner, Y; Aversa, Franco; Falini, Brunangelo; Velardi, Andrea | |
| [The Haemolymphopathology Italian Group (H.I.G.): an essential resource for the new technical and organization problems troubling modern haemolymphopathology diagnostics] | 2006 | Paulli, M.; Artusi, T.; Baroni, C.; Carbone, A.; Coggi, G.; Di Lollo, S.; Facchetti, F.; Falini, Brunangelo; Et, a. L. | |
| A BRAF-mutated case of hairy cell leukaemia lacking Annexin-A1 expression | 2018 | Simonetti, Edoardo; Ascani, Stefano; Volpetti, Stefano; Sabattini, Elena; Falini, Brunangelo; Tiacci, Enrico | |
| A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin | 2016 | Cavalli, Marzia; Ilari, Caterina; Del Giudice, Ilaria; Marinelli, Marilisa; Della Starza, Irene; De Propris, Maria Stefania; De Novi, Lucia Anna; Nunes, Vittorio; Cafforio, Luciana; Raponi, Sara; Mancini, Francesca; Mauro, Francesca Romana; Tiacci, Enrico; Falini, Brunangelo; Guarini, Anna; Foà, Robin | |
| A case of JAK2 V617F-positive myelodisplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. | 2011 | Forghieri, F.; Morselli, M.; Potenza, L.; Maccaferri, M.; Pedrazzi, L.; Coluccio, V.; Barozzi, P.; Vallerini, D.; Riva, G.; Zanetti, E.; Quarelli, C.; Bonacorsi, G.; Artusi, T.; Zaldini, P.; Zucchini, P.; Marasca, R.; Narni, F.; Falini, Brunangelo; Torelli, G.; Luppi, M. | |
| A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. | 2011 | Forghieri, F; Morselli, M; Potenza, L; Maccaferri, M; Pedrazzi, L; Coluccio, V; Barozzi, P; Vallerini, D; Riva, G; Zanetti, E; Quarelli, C; Bonacorsi, G; Artusi, T; Zaldini, P; Zucchini, P; Marasca, R; Narni, F; Falini, Brunangelo; Torelli, G; Luppi, M. | |
| A curious novel combination of nucleophosmin (Npm1) gene mutations leading to aberrant cytoplasmic dislocation of npm1 in acute myeloid leukemia (aml) | 2021 | Venanzi, A.; Rossi, R.; Martino, G.; Annibali, O.; Avvisati, G.; Mameli, M. G.; Sportoletti, P.; Tiacci, E.; Falini, B.; Martelli, M. P. | |
| A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells | 2000 | Falini, Brunangelo; Fizzotti, M.; Pucciarini, A.; Bigerna, B.; Marafiori, T.; Gambacorta, M.; Pacini, R.; Alunni, C.; Natali Tanci, L.; Ugolini, B.; Sebastiani, C.; Cattoretti, G.; Pileri, S.; Dalla Favera, R.; Stein, H. | |
| A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. | 2000 | Trinei, M.; Lanfrancone, L.; Campo, E.; Pulford, K.; Mason, D.; Pelicci, P.; Falini, Brunangelo | |
| A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation | 2015 | Abate, F; Todaro, M; van der Krogt, J. A; Boi, M; Landra, I; Machiorlatti, R; Tabbò, F; Messana, K; Abele, C; Barreca, A; Novero, D; Gaudiano, M; Aliberti, S; Di Giacomo, F; Tousseyn, T; Lasorsa, E; Crescenzo, R; Bessone, L; Ficarra, E; Acquaviva, A; Rinaldi, A; Ponzoni, M; Longo, D. L; Aime, S; Cheng, M; Ruggeri, B; Piccaluga, P. P; Pileri, S; Tiacci, Enrico; Falini, Brunangelo; Pera Gresely, B; Cerchietti, L; Iqbal, J; Chan, W. C; Shultz, L. D; Kwee, I; Piva, R; Wlodarska, I; Rabadan, R; Bertoni, F; Inghirami, G. | |
| A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) | 2008 | Liso, A; Castiglione, F; Cappuccio, A; Stracci, Fabrizio; Schlenk, Rf; Amadori, S; Thiede, C; Schnittger, S; Valk, Pj; Döhner, K; Martelli, Massimo Fabrizio; Schaich, M; Krauter, J; Ganser, A; Martelli, Maria Paola; Bolli, N; Löwenberg, B; Haferlach, T; Ehninger, G; Mandelli, F; Döhner, H; Michor, F; Falini, Brunangelo | |
| A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice. | 2013 | Mupo, A; Celani, L; Dovey, O; Cooper, Jl; Grove, C; Rad, R; Sportoletti, Paolo; Falini, Brunangelo; Bradley, A; Vassiliou, Gs | |
| A scale of "bad" co-mutations in NPM1-driven AML | 2017 | Falini, Brunangelo; Sportoletti, Paolo | |
| A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study | 2016 | Chiaretti, S.; Vitale, A.; Vignetti, M.; Piciocchi, A.; Fazi, P.; Elia, L.; Falini, B.; Ronco, F.; Ferrara, F.; De Fabritiis, P.; Luppi, M.; La Nasa, G.; Tedeschi, A.; Califano, C.; Fanin, R.; Dore, F.; Mandelli, F.; Meloni, G.; Foa, R. | |
| Aberrant cytoplasmic expression of C-terminal-truncated NPM leukaemic mutant is dictated by tryptophans loss and a new NES motif. | 2007 | Falini, Brunangelo; Albiero, E.; Bolli, N.; De Marco, M.; Madeo, D.; Martelli, Massimo Fabrizio; Nicoletti, Ildo; Rodeghiero, F. | |
| Aberrant hypermutation of PIM1, PAX5, RhoH/TTF and cMYC in nodular lymphocyte predominance Hodgkin's disease | 2005 | Falini, Brunangelo; Liso, Arcangelo; Et, a. L. | |
| Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. | 2006 | Liso, A; Capello, D; Marafioti, T; Tiacci, E; Cerri, M; Distler, V; Paulli, M; Carbone, A; Delsol, G; Campo, E; Pileri, S; Pasqualucci, L; Gaidano, G; Falini, B. | |
| Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. | 2006 | Falini, Brunangelo; Bigerna, B; Pucciarini, A; Tiacci, Enrico; Mecucci, Cristina; Morris, Sw; Bolli, Niccolo'; Rosati, R; Hanissian, S; Ma, Z; Sun, Y; Colombo, E; Arber, Da; Pacini, R; LA STARZA, Roberta; Verducci Galletti, B; Liso, A; Martelli, Maria Paola; Diverio, D; Pelicci, Pg; Lo Coco, F; Martelli, Massimo Fabrizio | |
| Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML. | 2008 | Martelli, Maria Paola; Manes, N; Pettirossi, V; Liso, A; Pacini, R; Mannucci, R; Zei, T; Bolli, Niccolo'; di Raimondo, F; Specchia, G; Nicoletti, Ildo; Martelli, Mf; Falini, Brunangelo | |
| Actinomycin d targets npm1c-primed mitochondria to restore pml-driven senescence in aml therapy | 2021 | Wu, H. -C.; Rerolle, D.; Berthier, C.; Hleihel, R.; Sakamoto, T.; Quentin, S.; Benhenda, S.; Morganti, C.; Wu, C.; Conte, L.; Rimsky, S.; Sebert, M.; Clappier, E.; Souquere, S.; Gachet, S.; Soulier, J.; Durand, S.; Trowbridge, J. J.; Benit, P.; Rustin, P.; Hajj, H. E.; Raffoux, E.; Ades, L.; Itzykson, R.; Dombret, H.; Fenaux, P.; Espeli, O.; Kroemer, G.; Brunetti, L.; Mak, T. W.; Lallemand-Breitenbach, V.; Bazarbachi, A.; Falini, B.; Ito, K.; Martelli, M. P.; de The, H. |